Feed aggregator

Landing a Job Offer: How to Overcome Objections During an Interview

Biospace news - Mon, 12/02/2019 - 02:00
Be ready by anticipating and countering objections the employer might raise.

Kodiak Sciences Inks Royalty-Based R&D Development Deal for $225 Million

Biospace news - Mon, 12/02/2019 - 02:00
Under the terms of the deal with BBA, BBA acquired a capped 4.5% royalty on net sales of KSI-301 that will be paid upon marketing approval.

Imfinzi granted FDA Priority Review for the treatment of patients with extensive-stage small cell lung cancer

World Pharma News - Fri, 11/29/2019 - 11:00
AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) and granted Priority Review for Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small cell lung cancer (SCLC).

Research Roundup: More Ties Between Alzheimer’s and Neuroinflammation and More

Biospace news - Fri, 11/29/2019 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Herpes Vaccine: Despite Setbacks, There is Still Hope

Biospace news - Fri, 11/29/2019 - 02:00
There are currently three antivirals approved by the U.S. Food and Drug Administration (FDA) for genital herpes. They are acyclovir (Sitavig and Zovirax), valacyclovir (Valtrex), and famciclovir (Famvir). There are no approved vaccines.

Top 10 Gene Sequencing Companies by Revenue

Biospace news - Fri, 11/29/2019 - 02:00
The gene sequencing industry has really taken off in the years since the Human Genome Project’s rough draft was announced in June 2000.

5 Impressive Questions to Ask in a Final Round Job Interview

Biospace news - Fri, 11/29/2019 - 02:00
The final interview is probably the most intense and important interview you’ll go through, and here you want to show your in-depth knowledge of your industry, the role, and the organization, so your questions should reflect this high level of preparedness and research.

Bayer selects Pharmaron as partner organization

World Pharma News - Thu, 11/28/2019 - 13:00
Bayer and Pharmaron have entered into a global collaboration agreement to develop new molecular entities for veterinary medicines. Under the collaboration, Bayer will fully leverage Pharmaron's Chemistry, Manufacturing and Controls (CMC) service platform.

Pharmacist-led interventions may help prevent cardiovascular disease

World Pharma News - Thu, 11/28/2019 - 11:00
With their expertise in the safe and effective use of medications, pharmacists can help in the management of chronic diseases. A review and analysis published in the British Journal of Clinical Pharmacology indicates that initiatives - such as patient education, medication review, and physical assessments - led by pharmacists can make important contributions to the prevention of cardiovascular disease.

BioSpace Global Roundup, Nov. 28

Biospace news - Thu, 11/28/2019 - 02:00
Companies from across the globe provide updates on their businesses and pipelines.

6 Things About Biopharma to Be Thankful For

Biospace news - Thu, 11/28/2019 - 02:00
In light of the Thanksgiving season, here are six things about biopharma that we are thankful for.

5 Advantages of Looking for a New Job Over the Holidays

Biospace news - Thu, 11/28/2019 - 02:00
Many job seekers take it for granted that the holidays are not the best time to be on the job market, so they suspend their job hunt until after the new year. Others get distracted by all of the holiday hullabaloo and don’t put as much time and effort into their search as they need to.

Merck’s Keytruda: A Deep Dive

Biospace news - Thu, 11/28/2019 - 02:00
Merck’s checkpoint inhibitor Keytruda (pembrolizumab) has been approved for 21 indications, but you’d better keep up, because it seems the drug is approved for some new indication or combination just about every week.

FDA grants priority review to Roche’s risdiplam for spinal muscular atrophy

World Pharma News - Wed, 11/27/2019 - 13:00
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review for risdiplam, an investigational survival motor neuron-2 (SMN-2) splicing modifier for SMA. Risdiplam is designed to increase and sustain SMN protein levels both throughout the central nervous system and peripheral tissues of the body.

A protein tag to study the immune system

World Pharma News - Wed, 11/27/2019 - 11:00
Researchers from VIB-UGent Center for Medical Biotechnology, University of Iowa (USA) and other collaborators, developed a novel approach to better understand a basic defense mechanism of our immune system. Central is ISG15, a small protein with a role in the immune system. With the newly developed method, scientists can now identify and study proteins tagged with ISG15, allowing them to

FDA Approves Sanofi’s Toujeo to Treat Childhood Type 1 Diabetes

Biospace news - Wed, 11/27/2019 - 02:00
Previously, Toujeo was approved only for adults aged 18 years and older.

Following Civil Settlements, Opioid Drugmakers and Distributors Could Face Criminal Charges

Biospace news - Wed, 11/27/2019 - 02:00
The companies are facing questions in a criminal probe regarding their marketing distribution practices related to the sale of opioids.

Former MiMedx CEO Parker Petit Indicted on Fraud Charges

Biospace news - Wed, 11/27/2019 - 02:00
The government said Petit and former Chief Operating Officer William Taylor engaged in a scheme to “fraudulently inflate” the revenue of MiMedx.

COPD Market Expected to Grow as Number of Cases Continues Rising

Biospace news - Wed, 11/27/2019 - 02:00
While there is no cure for the disease, there are a number of drugs that have been approved to treat the illness. And with the growing number of cases, the drug market for COPD is expected to dramatically increase as well.

How to Show Your Co-Workers You’re Thankful for Them

Biospace news - Wed, 11/27/2019 - 02:00
Regardless of your situation, the holidays are a busy time for just about anyone. But don’t forget about the people you’ve been sitting next to all day, every day for the better part of a year — your co-workers.